Johnson & Johnson’s investigational seltorexant shows numerically higher response in patients with depression with insomnia symptoms, with fewer side effects compared to quetiapine XR - Johnson & Johnson
Submitted by Anonymous (not verified) on Mon, 09/22/2025 - 12:04
